Insider · CIK 0001466086

Lorianne Masuoka K.

Reports to the SEC for 5 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001466086

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-22	DMACDiaMedica Therapeutics Inc. · Stock option (right to buy)A Award	Chief Medical Officer	AAward	+285K sh	—	—	285,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	$20.00	−$40K	2,000
2023-03-02	OPIANT PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	$20.00	−$40K	0
2023-03-02	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	−5,000 sh	—	—	0
2022-06-14	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	4,000
2021-06-15	OPIANT PHARMACEUTICALS, INC.A Award	Director	AAward	+2,000 sh	—	—	2,000
2021-03-18	OPIANT PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-08-21	MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2019-02-26	MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award	Chief Medical Officer	AAward	+200K sh	—	—	200,000
2017-12-06	MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award	Chief Medical Officer	AAward	+150K sh	—	—	150,000
2015-12-31	INVIVO THERAPEUTICS HOLDINGS CORP.A Award	Chief Medical Officer	AAward	+265 sh	$6.12	+$1,621.8	265
2015-12-10	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+115K sh	—	—	115,050
2015-03-02	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+500K sh	—	—	500,000
2011-02-08	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Medical Officer	AAward	+75K sh	$10.69	+$802K	75,000
2010-02-01	NKTRNEKTAR THERAPEUTICS · Stock OptionA Award	Chief Medical Officer	AAward	+125K sh	$11.34	+$1.42M	125,000

Recent filings

Accepted (ET)
Jan 234
Lorianne Masuoka K.0001235802-24-000015
SEC(opens sec.gov)
Mar 34
Lorianne Masuoka K.0001385508-23-000059
SEC(opens sec.gov)
Jun 144
Lorianne Masuoka K.0001385508-22-000086
SEC(opens sec.gov)
Jun 164
Lorianne Masuoka K.0001385508-21-000084
SEC(opens sec.gov)
Mar 224
Lorianne Masuoka K.0001385508-21-000052
SEC(opens sec.gov)
Aug 234
Lorianne Masuoka K.0001104659-19-047144
SEC(opens sec.gov)
Feb 284
Lorianne Masuoka K.0001104659-19-011640
SEC(opens sec.gov)
Dec 84
Lorianne Masuoka K.0001104659-17-072520
SEC(opens sec.gov)
Jan 225
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-16-017956
SEC(opens sec.gov)
Dec 114
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-15-016172
SEC(opens sec.gov)
Mar 44
INVIVO THERAPEUTICS HOLDINGS CORP.0001179110-15-004187
SEC(opens sec.gov)
Feb 104
Lorianne Masuoka K.0001181431-11-009121
SEC(opens sec.gov)
Feb 34
Lorianne Masuoka K.0001181431-10-006211
SEC(opens sec.gov)

Companies

Address

C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD

SAN CARLOS, CA, 94070